ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0429

Exploring the Impact of Autoimmune Rheumatic Diseases on Human Milk Macronutrient Composition

Rashmi Dhital1, Kerri Bertrand2, Essi Heinonen3 and Christina Chambers4, 1UC San Diego, Brentwood, TN, 2UC San Diego, San Diego, CA, 3UC San Diego, La Jolla, CA; Karolinska Institutet, Stockholm, Sweden, San Diego, CA, 4University of California, San Diego, La Jolla, CA

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, rheumatoid arthritis, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic inflammation in autoimmune rheumatic diseases (ARDs) may alter human milk composition, akin to changes observed in other inflammatory states, indirectly impacting infant health, yet data are nearly non-existent.

Methods: We utilized the Human Milk Biorepository (HMB), located at UC San Diego, to compare milk composition, specifically fat, carbohydrate, protein, and calories, between women with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) and healthy controls matched on infant and maternal age and infant sex.  Descriptive characteristics were compared using Fisher’s exact test for categorical and Mann-Whitney U test for continuous variables. After trimming outliers to normalize the distribution of macronutrients, multivariable linear regression analyses were conducted to estimate the coefficients and 95% confidence intervals (CIs) with ARDs as the exposure and macronutrient composition as the outcome. Model a was adjusted for maternal age, child age, and infant sex; Model b additionally adjusted for body mass index, parity, frequency of feeds, time of milk collection, and hours since the last feed; and Model c incorporated all these variables and the milk storage length of the milk samples.

Results: We analyzed samples from 74 mothers with ARDs (13 SLE, 58 RA, and three with both) and 31 healthy controls. The median age of mothers in the ARD and non-ARD groups were 33.85 and 35.01 years, respectively. The children had a median age of 4.8 months at the time of milk collection. Notably, the median storage duration of the analyzed samples was significantly longer in the ARD group (53 months) compared to 3 months in controls (Table 1). The median (Interquartile range [IQR]) levels of nutrients for ARD vs control groups were: carbohydrate [8.57 (7.80-8.99) vs 9.02 (8.73-9.31) g/dl, p=0.001], fat [3.62 (2.76-4.60) vs 3.45 (2.82-4.25) g/dl, p=0.94], protein [0.88 (0.64-1.09) vs 0.55 (0.37-0.69) g/dl, p=0.0004] and energy [70.81 (61.47-80.21) vs 70.74 (70.74-78.89) kCal/dl, p=0.78], respectively.

The unadjusted linear regression model revealed higher average protein content in ARD by 0.26 g/dl (95% CI 0.73 – 0.45), which remained elevated in Models a and b. However, in the fully adjusted Model c, there was no difference in milk protein between ARD and non-ARD groups (p = 0.19). Conversely, the levels of carbohydrates were consistently lower in the ARD group, by 0.71 g/dL (95% CI -1.19, -0.24) in the fully adjusted model. There were no differences in fat or total energy content between groups (Table 2).

Conclusion: ARDs may alter the nutritional composition of human milk, particularly by reducing carbohydrate content. However, as the carbohydrate levels in ARD groups are still within the normal range reported in the literature the clinical implications require further investigation. Although findings indicated higher protein in the ARD group, the difference diminished after accounting for the length of milk storage, highlighting an area for further study. This research lays the groundwork for detailed research into human milk composition in ARD patients, including for distinct ARD subgroups, and across various ARD treatments.

Supporting image 1

Comparison of maternal, child, and breast milk collection characteristics between mothers with and without autoimmune rheumatic diseases

Supporting image 2

Comparison of maternal, child, and breast milk collection characteristics among groups
with and without autoimmune rheumatic diseases


Disclosures: R. Dhital: None; K. Bertrand: None; E. Heinonen: None; C. Chambers: Amgen, 5, AstraZeneca, 5, Genzyme Sanofi-Aventis, 5, Gerber Foundation, 5, Gilead, 5, GlaxoSmithKlein(GSK), 5, Hoffman La-Roche-Genentech, 5, Janssen Pharmaceuticals, 5, Leo Pharma, 5, Novartis, 5, Pfizer, 5, Regeneron, 5, Sanofi, 5, Sun Pharma Global FZE, 5, Takeda Pharmaceutical Company Limited, 5, UCB Pharma, USA, 5.

To cite this abstract in AMA style:

Dhital R, Bertrand K, Heinonen E, Chambers C. Exploring the Impact of Autoimmune Rheumatic Diseases on Human Milk Macronutrient Composition [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/exploring-the-impact-of-autoimmune-rheumatic-diseases-on-human-milk-macronutrient-composition/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exploring-the-impact-of-autoimmune-rheumatic-diseases-on-human-milk-macronutrient-composition/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology